Abstract
Cinnamaldehyde (CNA) is a primary constituent found in cinnamon (Cortex cinnamomi). Although antidiabetic and anti-inflammatory activities of cinnamon extract have been investigated in recent years, whether CNA is responsible for these activities is yet to be explored. In the present study, we investigated the protective effect of CNA on streptozotocin (STZ)-induced β-cell dysfunction in RINm5F rat insulinoma cells. CNA markedly inhibited nitric oxide (NO) and prostaglandin E2 (PGE2) productions in concentration-dependent manners. Parallel with these observations, the protein and mRNA levels of inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 enzymes were inhibited by CNA in concentration-dependent manners. CNA also inhibited STZ-induced nuclear factor (NF)-κB activation via the prevention of inhibitory κBα (IκBα) phosphorylation and degradation. Moreover, CNA significantly suppressed STZ-induced phosphorylations of extracellular signalregulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38 mitogen-activated protein kinase (MAPK) in concentration-dependent manners. These results suggest that CNA is an active constituent of the cinnamon, and CNA protects against STZ-induced pancreatic β-cell damage by down-regulations of iNOS and COX-2 gene expression through blocking of NF-κB and MAPKs activities.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Jorns A, Gunther A, Hedrich HJ, Wedekind D, Tiedge M, Lenzen S. Immune cell infiltration, cytokine expression, and β-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes 54: 2041–2052 (2005)
Kanazawa Y, Komeda K, Sato S, Mori S, Akanuma K, Takaku F. Non-obese-diabetic mice: Immune mechanisms of pancreatic β-cell destruction. Dibetologia 27: 113–115 (1984)
Amirshahokhi K, Dehpour AR, Hadjati J, Sotoudeh M, Ghazi-Khansari M. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice. Toxicol. Appl. Pharm. 232: 119–124 (2008)
Kwon KB, Kim EK, Jeong ES, Lee YH, Lee YR, Park JW, Ryu DG, Park BH. Cortex cinnamomi extract prevents streptozotocinand cytokine-induced β-cell damage by inhibiting NF-κB. World J. Gastroentero. 12: 4331–4337 (2006)
Kim JD, Kang SM, Seo BI, Choi HY, Choi HS, Ku SK. Antidiabetic activity of SMK001, a poly herbal formula in streptozotocin induced diabetic rats: Therapeutic study. Biol. Pharm. Bull. 29: 477–482 (2006)
Kwon NS, Lee SH, Choi CS, Kho T, Lee HS. Nitric oxide generation from streptozotocin. FASEB J. 8: 529–533 (1994)
Toriizuka K. Basic lecture of Kampo medicine: Pharmacological effect of cinnamon. Kampo Med. 11: 431–436 (1998)
Barceloux DG. Cinnamon (Cinnamomum species). pp. 327–335. In: Medical Toxicology of Natural Substances: Foods, Fungi, Medicinal Herbs, Toxic Plants, and Venomous Animals. Barceloux DG (ed). John Wiley & Sons, Inc., Hoboken, NJ, USA (2009).
Anderson RA, Broadhurst CL, Polansky MM, Schmidt WF, Khan A, Flanagan VP, Schoene NW, Graves DJ. Isolation and characterization of polyphenol type-A oligomers from cinnamon with insulin-like biological activity. J. Agr. Food Chem. 52: 65–70 (2004)
Chao LK, Hua KF, Hsu HY, Cheng SS, Lin IF, Chen CJ, Chen ST, Chang ST. Cinnamaldehyde inhibits pro-inflammatory cytokines sretion from monocytes/macrophages though suppression of intracellular signaling. Food Chem. Toxicol. 46: 220–231 (2007)
Gowder SJ, Devaraj H. Effect of the food flavour cinnamaldehyde on the antioxidant status of rat kidney. Basic Clin. Pharmacol. 99: 379–382 (2006)
Pei RS, Zhou F, Ji BP, Xu J. Evaluation of combined antibacterial effects of eugenol, cinnamaldehyde, thymol, and carvacrol against E. coli with an improved method. J. Food Sci. 74: 379–383 (2009)
Zhang W, Xu YC, Guo FJ, Meng Y, Li ML. Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. Chinese Med. J.-Peking 121: 2124–2128 (2008)
Reddy AM, Seo JH, Ryu SY, Kim YS, Kim YS, Min KR, Kim Y. Cinnamaldehyde and 2-methoxycinnamaldehyde as NF-κB inhibitors from Cinnamomum cassia. Planta Med. 70: 823–827 (2004)
Guo JY, Huo H, Zhao BS, Liu HB, Li LF, Ma YY, Guo SY, Jiang TL. Cinnamaldehyde reduces IL-1β-induced cyclooxygenase-2 activity in rat cerebral microvascular endothelial cells. Eur. J. Pharmacol. 537: 174–180 (2006)
Liao BC, Hsieh CW, Liu YC, Tzeng TT, Sun YW, Wung BS. Cinnamaldehyde inhibits the tumor necrosis factor-α-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-κB activation: Effects upon IκB and Nrf2. Toxicol. Appl. Pharm. 229: 161–171 (2008)
Moncada S, Palmer RM. Biosynthesis and action of nitric oxide. Semin. Perinatol. 15: 16–19 (1991)
Akli S, Chelly J, Lacorte JM, Poenaru L, Kahn A. Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCRamplified cDNA fragments. Genomics 11: 124–134 (1991)
Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res. Clin. Pr. 62: 139–148 (2003)
Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul A, Devasagayam T. Indian herbs and herbal drugs used for the treatment of diabetes. J. Clin. Biochem. Nutr. 40: 163–173 (2007)
Khan A, Bryden NA, Polansky MM, Anderson RA. Insulin potentiating factor and chomium content of selected foods and spices. Biol. Trace Elem. Res. 24: 183–188 (1990)
Khan A, Safdar M, Khan MMA, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26: 3215–3218 (2003)
Jia Q, Liu X, Wu X, Wang R, Hu X, Li Y, Huang C. Hypoglycemic activity of a polyphenolic oligomer-rich extract of Cinnamomum parthenoxylon bark in normal and streptozotocin-induced diabetic rats. Phytomedicine 16: 744–750 (2009)
Kim W, Khil LY, Clark R, Bok SH, Kim EE, Lee S, Jun HS, Yoon JW. Naphthalenemethyl ester derivative of dihydroxyhydrocinnamic acid, a component of cinnamon, increases glucose disposal by enhancing translocation of glucose transporter 4. Diabetologia 49: 2437–2448 (2006)
Subash BP, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde—A potential antidiabetic agent. Phytomedicine 14: 15–22 (2007)
Kim EK, Kwon KB, Song MY, Han MJ, Lee JH, Lee YR, Lee JH, Ryu DG, Park BH, Park JW. Flavonoids protect against cytokine-induced pancreatic β-cell damage though suppression of nuclear factor κB activation. Pancreas 35: 1–9 (2007)
Yang F, Bleich D. Transcriptional regulation of cyclooxygenase-2 gene in pancreatic β-cells. J. Biol. Chem. 279: 35403–35411 (2004)
Yun KJ, Kim JY, Kim JB, Lee KW, Jeong SY, Park HJ, Jung HJ, Cho YW, Yun K, Lee KT. Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-κB inactivation in RAW 264.7 macrophages: Possible involvement of the IKK and MAPK pathways. Int. Immunopharmacol. 8: 431–441 (2008)
Baeuerle PA, Baltimore D. NF-κB: Ten years after. Cell 87: 13–20 (1996)
Saccani S, Pantano S, Natoli G. Two waves of nuclear factor κB recruitment to target promoters. J. Exp. Med. 193: 1351–1359 (2001)
Karin M. How NF-κB is activated: The role of the IκB kinase (IKK) complex. Oncogene 18: 6867–6874 (1999)
Kefaloyianni E, Gaitanaki C, Beis I. ERK1/2 and p38-MAPK signalling pathways, though MSK1, are involved in NF-κB transactivation during oxidative stress in skeletal myoblasts. Cell Signal. 18: 2238–2251 (2006)
Pan MH, Lai CS, Wang YJ, Ho CT. Acacetin suppressed LPSinduced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Biochem. Pharmacol. 72: 1293–1303 (2006)
Kim YJ, Hwang SY, Oh ES, Oh S, Han IO. IL-1β, an immediate early protein sreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells though p38 MAPK and NF-κB pathways. J. Neurosci. Res. 84: 1037–1046 (2006)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yuan, H.D., Huang, B. & Chung, S.H. Protective effect of cinnamaldehyde on streptozotocin-induced damage in rat pancreatic β-cells. Food Sci Biotechnol 20, 1271–1276 (2011). https://doi.org/10.1007/s10068-011-0175-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10068-011-0175-6